MiMedx Group, Inc.
MiMedx Group, Inc. (MDXG) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MDXG · as of Jun 8, 2026
Key Statistics
Explore MiMedx Group, Inc. Data
mdxg stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 15 · Buy rate: 80.0%
The MDXG analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $10.00, representing +165.60% upside from the current price of $3.77.
Competitors & Peers
mdxg competitorsMDXG
ATAI
CVAC
DNTH
INBX
INVAStock Performance
Full HistoryAbout MiMedx Group, Inc.
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION proces…
what is mimedx group, inc. · mdxg stock overview · mimedx group, inc. company profile · who is mimedx group, inc. ceo · mdxg NASDAQ · mimedx group, inc. headquarters · mimedx group, inc. business segments
About Stock Overview & Key Data
MiMedx Group, Inc. (MDXG) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 12, 2008. As of the latest trading session, MDXG stock price is $3.77, with a market capitalization of $559.3M. The stock has returned -41.78% over the past 12 months and -44.53% year-to-date.
According to 15 Wall Street analysts, the consensus rating for MiMedx Group, Inc. stock is Buy, with an average 12-month price target of $10.00. In fiscal year 2025, MiMedx Group, Inc. reported revenue of $418.6M and net income of $48.6M. For detailed data — including MiMedx Group, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, MiMedx Group, Inc. (MDXG) stock price is $3.77. The stock is traded on NASDAQ under the ticker symbol MDXG. The 52-week range is $3.03 – $7.99.